ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Eukaryotic Gene Expression
インパクトファクター: 2.156 5年インパクトファクター: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.2013006666
pages 49-64

Brucella Virulence Mechanisms and Implications in Novel Vaccines and Drugs

Guangjun Gao
College of Pharmaceutical Science, Southwest University, Chongqing, 400716, China; Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, 100071, China
Yufei Wang
Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, 100071, China
Zeliang Chen
Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, 100071, China
Xingran Xu
College of Pharmaceutical Science, Southwest University, Chongqing, 400716, China
Jie Xu
School of Public Health, Research Center for Genomic Medicine, Jilin University; Institute of Disease Control and Prevention, Academy of Military Medical Science, Beijing, 100071, China

要約

Brucellosis, an infection caused by Brucella spp., is a common zoonosis in many parts of world. Human chronic infection is successfully established through contact with infected animals or their dirty products. The capacity of establishing and maintaining this persistent infection in the phagosomal compartment of host macro-phages is critical to their ability to produce chronic infections in their mammalian hosts. Bacterial virulence mechanisms play an important role in regulating during the infectious process, both to optimize the functioning of the virulence factors in promoting survival and thwarting host defenses and to produce an effective immune response against these virulence components. The availability of the genomic sequences and molecular strategies such as gene mutant technique provide an opportunity to identify the virulence mechanisms of Brucella. It will greatly accelerate our understanding of the infection of this pathogen and give us more clues to exploit new vaccines and drugs.


Articles with similar content:

Drugs That Target Gene Expression: An Overview
Critical Reviews™ in Eukaryotic Gene Expression, Vol.6, 1996, issue 1
Filippo Cavalieri
Important Biology Events and Pathways in Brucella Infection and Implications for Novel Antibiotic Drug Targets
Critical Reviews™ in Eukaryotic Gene Expression, Vol.23, 2013, issue 1
Guangjun Gao, Jie Xu
CRISPR-CAS Replacing Antiviral Drugs against HIV: An Update
Critical Reviews™ in Eukaryotic Gene Expression, Vol.30, 2020, issue 1
Muhammad Zubair Yousaf, Atif Yaqoob, Rabia Hashmat, Ziaur Rahman, Muhammad Imran, Khalid Mahmood Anjum
Experimental Approaches for Eliminating Latent HIV
Onco Therapeutics, Vol.6, 2015, issue 1-2
Matthew D. Marsden , Jerome A. Zack
Multifaceted Modulation of SIRT1 in Cancer and Inflammation
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 1-2
Yun Lu, Xi Chen, Guangwei Liu, Hui Yang, Yujing Bi, Zhengguo Zhang, Yiwei Chu, Jian Wang, Ruifu Yang, Ruoning Wang, Lixiang Xue